![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 213/74 | (2006.01) |
C07D 215/38 | (2006.01) | ||
C07D 241/44 | (2006.01) | ||
C07D 403/12 | (2006.01) | ||
A61K 31/4709 | (2006.01) | ||
A61K 31/4985 | (2006.01) | ||
A61P 3/10 | (2006.01) | ||
A61P 17/00 | (2006.01) | ||
A61P 19/10 | (2006.01) | ||
A61P 21/00 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 27/12 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
C07D 215/46 | (2006.01) | ||
C07D 215/42 | (2006.01) | ||
C07D 401/12 | (2006.01) | ||
A61P 9/10 | (2006.01) |
(11) | Number of the document | 2440547 |
(13) | Kind of document | T |
(96) | European patent application number | 10757474.1 |
Date of filing the European patent application | 2010-06-14 | |
(97) | Date of publication of the European application | 2012-04-18 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-30 |
(46) | Date of publication of the claims translation | 2023-03-10 |
(86) | Number | PCT/IB2010/052651 |
Date | 2010-06-14 |
(87) | Number | WO 2010/143169 |
Date | 2010-12-16 |
(30) | Number | Date | Country code |
09162630 | 2009-06-12 | EP | |
186552 P | 2009-06-12 | US | |
09305540 | 2009-06-12 | EP | |
186544 P | 2009-06-12 | US |
(72) |
TAZI, Jamal , FR
MAHUTEAU, Florence , FR
NAJMAN, Romain , FR
SCHERRER, Didier , FR
CAMPOS, Noëlie , FR
GARCEL, Aude , FR
|
(73) |
ABIVAX ,
7-11 Boulevard Haussmann, 75009 Paris,
FR
Centre National de la Recherche Scientifique (C.N.R.S.) , 3 rue Michel-Ange, 75794 Paris Cedex 16, FR Institut Curie , 26, rue d'Ulm, 75248 Paris Cedex 05, FR UNIVERSITE DE MONTPELLIER , 163 rue Auguste Broussonnet, 34090 Montpellier, FR |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Naujos cheminės molekulės, kurios slopina splaisingo mechanizmą, skirtos gydyti ligas, atsirandančias dėl splaisingo defektų |
New chemical molecules that inhibit the splicing mechanism for the treatment of diseases resulting from splicing defects |
Payment date | Validity (years) | Amount | |
2025-05-23 | 16 | 347.00 EUR |
2026-06-14 |